Literature DB >> 29522685

Ligand-Based NMR Study of C-X-C Chemokine Receptor Type 4 (CXCR4)-Ligand Interactions on Living Cancer Cells.

Diego Brancaccio1, Donatella Diana2, Salvatore Di Maro3, Francesco Saverio Di Leva1, Stefano Tomassi3, Roberto Fattorusso3, Luigi Russo3, Stefania Scala4, Anna Maria Trotta4, Luigi Portella4, Ettore Novellino1, Luciana Marinelli1, Alfonso Carotenuto1.   

Abstract

Peptide-binding G protein-coupled receptors (GPCRs) are key effectors in numerous pathological and physiological pathways. The assessment of the receptor-bound conformation of a peptidic ligand within a membrane receptor such as a GPCR is of great impact for a rational drug design of more potent analogues. In this work, we applied multiple ligand-based nuclear magnetic resonance (NMR) methods to study the interaction of peptide heptamers, derived from the C-X-C Motif Chemokine 12 (CXCL12), and the C-X-C Chemokine Receptor Type 4 (CXCR4) on membranes of human T-Leukemia cells (CCRF-CEM cells). This study represents the first structural investigation reporting the receptor-bound conformation of a peptide to a GPCR directly on a living cell. The results obtained in the field of CXCL12/CXCR4 are proofs of concept, although important information for researchers dealing with the CXCR4 field arises. General application of the presented NMR methodologies is possible and surely may help to boost the development of new therapeutic agents targeting GPCRs.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29522685     DOI: 10.1021/acs.jmedchem.7b01830

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

Review 1.  GPCR drug discovery: integrating solution NMR data with crystal and cryo-EM structures.

Authors:  Ichio Shimada; Takumi Ueda; Yutaka Kofuku; Matthew T Eddy; Kurt Wüthrich
Journal:  Nat Rev Drug Discov       Date:  2018-11-09       Impact factor: 84.694

2.  HOPPI-NMR: Hot-Peptide-Based Screening Assay for Inhibitors of Protein-Protein Interactions by NMR.

Authors:  Diego Brancaccio; Salvatore Di Maro; Linda Cerofolini; Stefano Giuntini; Marco Fragai; Claudio Luchinat; Stefano Tomassi; Antonio Limatola; Pasquale Russomanno; Francesco Merlino; Ettore Novellino; Alfonso Carotenuto
Journal:  ACS Med Chem Lett       Date:  2020-02-20       Impact factor: 4.345

3.  Modulation of the 20S Proteasome Activity by Porphyrin Derivatives Is Steered through Their Charge Distribution.

Authors:  Marco Persico; Anna Maria Santoro; Alessandro D'Urso; Danilo Milardi; Roberto Purrello; Alessandra Cunsolo; Marina Gobbo; Roberto Fattorusso; Donatella Diana; Manuela Stefanelli; Grazia R Tundo; Diego Sbardella; Massimo Coletta; Caterina Fattorusso
Journal:  Biomolecules       Date:  2022-05-24

Review 4.  Structural biology of human GPCR drugs and endogenous ligands - insights from NMR spectroscopy.

Authors:  Guillaume Ferré; Matthew T Eddy
Journal:  Methods       Date:  2020-09-08       Impact factor: 3.608

5.  A highly selective and potent CXCR4 antagonist for hepatocellular carcinoma treatment.

Authors:  Jen-Shin Song; Chih-Chun Chang; Chien-Huang Wu; Trinh Kieu Dinh; Jiing-Jyh Jan; Kuan-Wei Huang; Ming-Chen Chou; Ting-Yun Shiue; Kai-Chia Yeh; Yi-Yu Ke; Teng-Kuang Yeh; Yen-Nhi Ngoc Ta; Chia-Jui Lee; Jing-Kai Huang; Yun-Chieh Sung; Kak-Shan Shia; Yunching Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-30       Impact factor: 11.205

6.  Structure of the agonist 12-HHT in its BLT2 receptor-bound state.

Authors:  Fabrice Giusti; Marina Casiraghi; Elodie Point; Marjorie Damian; Jutta Rieger; Christel Le Bon; Alexandre Pozza; Karine Moncoq; Jean-Louis Banères; Laurent J Catoire
Journal:  Sci Rep       Date:  2020-02-14       Impact factor: 4.379

7.  Cooperative Binding of the Cationic Porphyrin Tris-T4 Enhances Catalytic Activity of 20S Proteasome Unveiling a Complex Distribution of Functional States.

Authors:  Anna Maria Santoro; Alessandro D'Urso; Alessandra Cunsolo; Danilo Milardi; Roberto Purrello; Diego Sbardella; Grazia R Tundo; Donatella Diana; Roberto Fattorusso; Antonio Di Dato; Antonella Paladino; Marco Persico; Massimo Coletta; Caterina Fattorusso
Journal:  Int J Mol Sci       Date:  2020-09-29       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.